PON2 and prostate carcinoma: Till now, upregulated levels of PON2 have been detected in different types of cancer cells, such as hepatocellular carcinoma, prostate cancer and pediatric acute lymphoblastic leukemia, and it has been suggested a possible involvement of PON2 in apoptotic escape of tumor cells [6, 13–15].